PI
AUPH icon

PFG Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

PFG Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Sell
30,600
-14,290
-32% -$228K 0.02% 643
2026
Q1 		$665K Buy
44,890
+10,450
+30% +$153K 0.03% 488
2025
Q4 		$549K Buy
34,440
+9,740
+39% +$138K 0.03% 543
2025
Q3 		$273K Sell
24,700
-3,400
-12% -$37.1K 0.01% 833
2025
Q2 		$238K Hold
28,100
– – 0.01% 834
2025
Q1 		$226K Buy
28,100
+1,250
+5% +$10.1K 0.01% 835
2024
Q4 		$241K Hold
26,850
– – 0.02% 808
2024
Q3 		$197K Sell
26,850
-1,900
-7% -$11.8K 0.01% 896
2024
Q2 		$164K Buy
28,750
+7,900
+38% +$41.6K 0.01% 839
2024
Q1 		$104K Sell
20,850
-24,550
-54% -$167K 0.01% 961
2023
Q4 		$408K Buy
45,400
+100
+0.2% +$824 0.08% 284
2023
Q3 		$352K Sell
45,300
-1,000
-2% -$9.78K 0.07% 318
2023
Q2 		$448K Hold
46,300
– – 0.08% 272
2023
Q1 		$507K Buy
+46,300
New +$408K 0.1% 222

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFG Investments's AUPH Position: Q2 2026 in Review

PFG Investments reduced its Aurinia Pharmaceuticals (AUPH) stake by 32% in Q2 2026, selling an estimated $228K and leaving 30,600 shares worth $519K. The position accounts for 0.02% of the portfolio, ranked #643.

PFG Investments first reported a position in AUPH in Q1 2023 and has held it in 14 quarters since. The position peaked at $665K in Q1 2026. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • PFG Investments held 30,600 shares of Aurinia Pharmaceuticals worth $519K as of Q2 2026.
  • PFG Investments sold 14,290 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $228K.
  • Aurinia Pharmaceuticals made up 0.02% of PFG Investments's portfolio in Q2 2026, its #643 holding.
  • PFG Investments first reported a position in Aurinia Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's Aurinia Pharmaceuticals position peaked at $665K in Q1 2026.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.